EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Susceptibility‐Guided Triple Therapy Achieves High Helicobacter pylori Eradication Regardless of Duration

Hoyoung Wang iD, Ji Yong Ahn iD, Hee Kyong Na iD, Kee Wook Jung iD, Jeong Hoon Lee iD, Do Hoon Kim iD, Kee Don Choi iD, Ho June Song iD, Gin Hyug Lee iD, Hwoon-Yong Jung iD, Jung Mogg Kim iD

Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3433-3441

DOI: 10.1111/jgh.70758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 27.09.2026. Verfasst von Hoyoung Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Amoxicillin, Clarithromycin. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean College of Helicobacter and Upper Gastrointestinal Research Foundation, Korean College of Helicobacter and Upper Gastrointestinal Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Although clarithromycin resistance is a major cause of empirical triple therapy failure for Helicobacter pylori eradication, the clinical relevance of amoxicillin susceptibility remains uncertain. We first compared eradication outcomes between empirical and susceptibility‐guided tailored triple therapy and then evaluated the influence of treatment duration and amoxicillin susceptibility among patients with clarithromycin‐susceptible strains receiving tailored triple therapy.

Methods

We retrospectively analyzed 807 patients receiving empirical or susceptibility‐guided tailored triple therapy in Korea from 2020 to 2024. Eradication outcomes were assessed in modified intention‐to‐treat (mITT) and per‐protocol (PP) populations by antibiotic susceptibility and treatment duration.

Results

Eradication rates were higher with tailored than empirical triple therapy (mITT: 92.9% vs. 69.3%, p < 0.001; PP: 93.7% vs. 69.7%, p < 0.001). Among patients with clarithromycin‐susceptible strains receiving tailored triple therapy, eradication rates were higher in amoxicillin‐susceptible than in amoxicillin‐resistant strains in the mITT analysis (94.0% vs. 86.8%, p = 0.034), whereas the difference was not statistically significant in the PP analysis (94.5% vs. 89.4%, p = 0.118). In the PP population, eradication rates did not differ significantly according to treatment duration in either amoxicillin‐susceptible ( p = 0.073) or amoxicillin‐resistant strains ( p = 0.884).

Conclusions

Among patients with clarithromycin‐susceptible strains receiving tailored triple therapy, eradication rates did not differ significantly according to treatment duration. However, these findings should be interpreted cautiously because the study may have been underpowered to detect modest but clinically meaningful differences. Amoxicillin susceptibility may be associated with eradication outcomes, although the statistical robustness of this association remains limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsAmoxicillinClarithromycinAnti-Bacterial AgentsProton Pump InhibitorsHumansDrug Therapy, CombinationRetrospective StudiesFemaleTreatment OutcomeTime FactorsMaleDrug Resistance, BacterialMiddle AgedDuration of TherapyAgedMicrobial Sensitivity TestsRepublic of Korea

Stichwörter der Autor:innen

Helicobacter pyloriamoxicillinclarithromycinproton pump inhibitorstreatment outcome

Substanzen

AmoxicillinClarithromycinAnti-Bacterial AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, South Korea.
  • Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Department of Microbiology, Hanyang University College of Medicine, Seoul, South Korea.

ORCID-Profile: Hoyoung Wang, Ji Yong Ahn, Hee Kyong Na, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung, Jung Mogg Kim

Förderung

  • Korean College of Helicobacter and Upper Gastrointestinal Research Foundation
  • Korean College of Helicobacter and Upper Gastrointestinal Research

Zitieren

APA

Wang, H., Ahn, J. Y., Na, H. K., Jung, K. W., Lee, J. H., Kim, D. H., Choi, K. D., Song, H. J., Lee, G. H., Jung, H. Y., & Kim, J. M. (2026). Susceptibility‐Guided Triple Therapy Achieves High Helicobacter pylori Eradication Regardless of Duration. Journal of Gastroenterology and Hepatology, 41(11), 3433-3441. https://doi.org/10.1111/jgh.70758

Vancouver

Wang H, Ahn JY, Na HK, Jung KW, Lee JH, Kim DH, et al. Susceptibility‐Guided Triple Therapy Achieves High Helicobacter pylori Eradication Regardless of Duration. Journal of Gastroenterology and Hepatology. 2026;41(11):3433-3441. doi:10.1111/jgh.70758

BibTeX
@article{Wang2026,
  author = {Wang, Hoyoung and Ahn, Ji Yong and Na, Hee Kyong and Jung, Kee Wook and Lee, Jeong Hoon and Kim, Do Hoon and Choi, Kee Don and Song, Ho June and Lee, Gin Hyug and Jung, Hwoon-Yong and Kim, Jung Mogg},
  title = {Susceptibility‐Guided Triple Therapy Achieves High Helicobacter pylori Eradication Regardless of Duration},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {3433--3441},
  doi = {10.1111/jgh.70758}
}
Kostenlos starten →